retatrutide trial duration Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a This data from Phase 3
Description
Why Choose Trifecta for GLP-1 Diet
Starting with tirzepatide at conservative doses provides a safer entry point for this population
duration depends on the drug, the indication (diabetes vs obesity), response, tolerance, cost, and long-term management plan
That being said only 4.1 % of patients stopped the 4mg dose which is less than the placebo arm
